Bryce A. Seifert

发表

Evaluating the clinical validity of gene-disease associations: an evidence-based framework developed by the Clinical Genome Resource

J. Michael Cherry, Heidi L. Rehm, Erin Rooney Riggs, 2017, bioRxiv.

Evaluating the clinical validity of gene-disease associations: an evidence-based framework developed by the Clinical Genome Resource

J. Michael Cherry, Avni Santani, Heidi L. Rehm, 2017, bioRxiv.

Erratum: Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine (American Journal of Human Genetics (2016) 98(6) (1067–1076) (S0002929716301069) (10.1016/j.ajhg.2016.04.011))

Sara Chandros Hull, Robert C. Green, Sean D. Mooney, 2016 .

Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes

C. Caleshu, J. Ware, Q. Wells, 2019, Circulation. Genomic and precision medicine.

Germline Analysis from Tumor–Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings

Lisle E. Mose, D. Hayes, J. Parker, 2016, Clinical Cancer Research.

Whole Exome Sequencing Identifies Truncating Variants in Nuclear Envelope Genes in Patients With Cardiovascular Disease

Christian R. Tilley, J. Berg, K. Wilhelmsen, 2017, Circulation. Cardiovascular genetics.

The global prevalence and ethnic heterogeneity of primary ciliary dyskinesia gene variants: a genetic database analysis.

R. Truty, B. Gaston, K. Nykamp, 2022, The Lancet. Respiratory medicine.

Chromosomal microarray analysis supplements exome sequencing to diagnose children with suspected inborn errors of immunity

Andrew J. Oler, E. Karlins, J. Lyons, 2023, Frontiers in Immunology.

Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)

David T. Miller, F. Mikhail, Lina Shao, 2021, Genetics in Medicine.